Article | August 15, 2017

Optimizing Clinical Outcomes For Challenging Molecules With Lipid-Based Drug Delivery Systems

Source: Catalent
Optimizing Clinical Outcomes For Challenging Molecules With Lipid-Based Drug Delivery Systems

Implementing a bioavailability enhancing formulation approach can positively impact safety, efficacy, and patient adherence, leading to successful clinical outcomes. An in-depth look at how lipid-based drug delivery systems (LBDDS) with softgel dosage form can be used as a bioavailability enhancing technology for successful clinical outcomes.